Saturday 17 October 2026
Export CV’s income statement to Excel — free account
CapsoVision, Inc.
CapsoVision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 15.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 92.6% and free cash flow fell 84.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.53
0.08
+1.24%
Follow CV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
2.38 | 5.57 | 0.00 | 0.00 |
+5 more quarters Free account |
P/S ratio |
27.25 | 25.51 | 19.37 | 17.75 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(45.05) | (57.03) | (34.15) | (39.48) | |
P/B ratio |
28.75 | 17.11 | 19.80 | 10.94 | |
Price to Tangible BV |
28.75 | 17.11 | 19.80 | 10.94 | |
EV/Sales |
26.60 | 24.19 | 18.62 | 16.34 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(13.28) | (13.70) | (11.04) | (10.01) | |
EV/FCF |
(13.25) | (13.64) | (11.00) | (9.97) | |
Quick Ratio |
2.20 | 3.70 | 2.85 | 4.24 | |
Current Ratio |
3.35 | 4.57 | 3.77 | 5.19 | |
Net Debt/EBITDA |
1.22 | 2.58 | 1.38 | 2.26 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.99 | 1.05 | 1.49 | 0.98 | |
Operating CF/Net income |
1.12 | 0.86 | 1.04 | 0.72 | |
Capex/Depreciation |
0.00 | (0.32) | (0.05) | (0.08) | |
Research and Development Expense of Revenue |
145.73% | 158.85% | 146.02% | 172.13% | |
Selling, General and Administrative Expense of Revenue |
113.70% | 142.80% | 94.36% | 108.62% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
15.84% | 11.96% | 5.03% | 8.68% | |
Graham Net Nets |
0.03 | 0.05 | 0.04 | 0.08 | |
Graham Number |
4.34 | 3.54 | 0.00 | 0.00 | |
Earnings Yield |
41.94% | 17.96% | (9.65%) | (154.35%) | |
Free Cash Flow Yield |
(7.37%) | (6.95%) | (8.74%) | (9.24%) | |
Revenue per Share |
0.07 | 0.06 | 0.16 | 0.08 | |
Operating CF per Share |
(0.17) | (0.13) | (0.31) | (0.12) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.17) | (0.13) | (0.31) | (0.12) | |
Cash per Share |
0.18 | 0.38 | 0.41 | 0.38 | |
Shareholders Equity per Share |
0.26 | 0.43 | 0.54 | 0.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.26 | 0.43 | 0.54 | 0.44 | |
Free Cash Flow |
(8.40) | (6.11) | (7.69) | (5.68) | |
Working Capital |
12.12 | 19.14 | 12.24 | 19.41 | |
Capital Expenditures |
0.00 | (0.05) | (0.01) | (0.01) | |
Net Current Asset Value |
11.88 | 18.78 | 11.77 | 18.83 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.02 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.06 | 1.96 | — | — | |
Average Payables |
0.82 | 1.05 | — | — | |
Average Inventory |
3.87 | 3.06 | — | — | |
Average Assets |
14.06 | 12.97 | 9.08 | 12.83 | |
Average Common Equity |
(62.91) | (54.64) | — | — |
Columns are period end dates